Clincosm LogoSign in Get a demo

Treatment Resistant Depression

Showing 51 - 75 of 168
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Treatment Resistant Depression Trial in United States (Liafensine, Placebo)

Recruiting
  • Treatment Resistant Depression
  • Huntsville, Alabama
  • +23 more
Oct 4, 2022

Computational Psychiatric Approach to Depression

Recruiting
  • Depression
  • Treatment Resistant Depression
  • clinical assessments
  • Winston-Salem, North Carolina
    Wake Forest School of Medicine
Oct 3, 2022

MDD, Treatment Resistant Depression, Bipolar Depression Trial in Rochester (Ketamine)

Enrolling by invitation
  • Major Depressive Disorder
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 12, 2022

MDD, Treatment Resistant Depression Trial in Houston (Deep Brain Stimulation Model 3387 Model 3389)

Active, not recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Deep Brain Stimulation Model 3387 Model 3389
  • Houston, Texas
    UT Center of Excellence on Mood Disorders
Sep 6, 2022

Treatment Resistant Depression Trial in Taipei City (Active standardized iTBS-DMPFC, Active high-dosage iTBS-DMPFC, Sham

Completed
  • Treatment Resistant Depression
  • Active standardized iTBS-DMPFC
  • +2 more
  • Taipei City, Taiwan
    Department of Psychiatry, Taipei Veterans General Hospital
Aug 28, 2022

Treatment Resistant Depression Trial in United States (MK-1942, Placebo)

Recruiting
  • Treatment Resistant Depression
  • Birmingham, Alabama
  • +30 more
Aug 8, 2022

Treatment Resistant Depression, MDD Trial in Innsbruck (Esketamine nasal spray, Electroconvulsive therapy)

Withdrawn
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Esketamine nasal spray
  • Electroconvulsive therapy
  • Innsbruck, Tyrol, Austria
    Medical University Innsbruck
Aug 2, 2022

Treatment Resistant Depression Trial in New York (Tianeptine Sodium)

Recruiting
  • Treatment Resistant Depression
  • Tianeptine Sodium
  • New York, New York
    1051 Riverside Drive
Jul 18, 2022

Treatment Resistant Depression Trial in La Jolla, Philadelphia (intermittent Theta Burst Stimulation)

Active, not recruiting
  • Treatment Resistant Depression
  • intermittent Theta Burst Stimulation
  • La Jolla, California
  • +1 more
Jul 13, 2022

Treatment Resistant Depression Trial in Worldwide (Vagal Nerve Simulation (VNS) Therapy)

Recruiting
  • Treatment Resistant Depression
  • Vagal Nerve Simulation (VNS) Therapy
  • Vienna, Austria
  • +17 more
Jul 11, 2022

Treatment Resistant Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +19 more
Jul 8, 2022

Treatment Resistant Depression, MDD Trial in New York (Repetitive Transcranial Magnetic Stimulation)

Recruiting
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Repetitive Transcranial Magnetic Stimulation
  • New York, New York
    Weill Cornell Medicine
Jun 24, 2022

Treatment Resistant Depression, Epilepsy Trial in Houston (Device: Directional Deep Brain Stimulation)

Recruiting
  • Treatment Resistant Depression
  • Epilepsy
  • Device: Directional Deep Brain Stimulation
  • Houston, Texas
    Baylor College of Medicine
Jun 16, 2022

ECT, Treatment Resistant Depression Trial in Saint Louis (Electroencephalographic (EEG), Closed loop acoustic stimulation

Recruiting
  • ECT
  • Treatment Resistant Depression
  • Electroencephalographic (EEG)
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine/Barnes-Jewish Hospital
Jun 14, 2022

Treatment Resistant Depression, MDD Trial in United States (AXS-05 (dextromethorphan-bupropion))

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • AXS-05 (dextromethorphan-bupropion)
  • Little Rock, Arkansas
  • +19 more
Jun 2, 2022

Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Active TBS-DMPFC, Sham TBS-DLPFC or DMPFC)

Recruiting
  • Treatment Resistant Depression
  • Active TBS-DLPFC
  • +2 more
  • Stanford, California
    Department of Psychiatry and Behavioral Sciences, Stanford Schoo
May 27, 2022

Treatment Resistant Depression, MDD Trial in Toronto (Bupivacaine Hydrochloride, Normal Saline)

Completed
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Bupivacaine Hydrochloride
  • Normal Saline
  • Toronto, Ontario, Canada
    St. Michael's Hospital
May 27, 2022

Treatment Resistant Depression Trial in Louisville (Discontinuation of serotonergic antidepressants, Continuation of

Recruiting
  • Treatment Resistant Depression
  • Discontinuation of serotonergic antidepressants
  • Continuation of serotonergic medications
  • Louisville, Kentucky
    University of Louisville, Department of Psychiatry and Behaviora
May 21, 2022

Treatment Resistant Depression Trial in Klecany (Psilocybin, Ketamine Hydrochloride, Midazolam Ph. Eur 9.0)

Recruiting
  • Treatment Resistant Depression
  • Klecany, Czechia
    National Institute of Mental Health
May 16, 2022

Treatment Resistant Depression Trial in Minneapolis (FEAST, FEAST RP, FEAST RC)

Recruiting
  • Treatment Resistant Depression
  • FEAST
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota
May 12, 2022

Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Sham TBS-DLPFC, Open label TBS-DLPFC)

Completed
Has Results
  • Treatment Resistant Depression
  • Active TBS-DLPFC
  • +2 more
  • Stanford, California
    Department of Psychiatry and Behavioral Sciences, Stanford Schoo
Apr 29, 2022

Treatment Resistant Depression, Problem Management Plus, Event-Related Potentials Trial in Hefei (PM+)

Recruiting
  • Treatment Resistant Depression
  • +2 more
  • PM+
  • Hefei, Anhui, China
    Anhui Medical University
May 3, 2022

Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Sham TBS-DLPFC)

Recruiting
  • Treatment Resistant Depression
  • Active TBS-DLPFC
  • Sham TBS-DLPFC
  • Stanford, California
    Department of Psychiatry and Behavioral Sciences, Stanford Schoo
May 5, 2022

Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Sham TBS-DLPFC)

Recruiting
  • Treatment Resistant Depression
  • Active TBS-DLPFC
  • Sham TBS-DLPFC
  • Stanford, California
    Department of Psychiatry and Behavioral Sciences, Stanford Schoo
May 5, 2022